BIOCYTOGEN-B News

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Dec 4 04:48 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTIDEAYA'S NOMINATION OF DEVELOPMENT CANDIDATE IDE034,A POTENTIAL FIRST-IN-CLASS B7H3/PTK7 TOPO-I-PAYLOADBISPECIFIC ADC AND OPTION EXERCISE

Nov 11 05:30 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 4 03:49 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 2 05:20 ET

BIOCYTOGEN-B: 2024 Interim Report

Sep 25 04:45 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 2 04:35 ET

BIOCYTOGEN-B: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 28 07:46 ET

BIOCYTOGEN-B: DATE OF BOARD MEETING

Aug 16 04:33 ET

BIOCYTOGEN-B: ANNOUNCEMENT ON PRELIMINARY FINANCIAL DATA FOR THESIX MONTHS ENDED JUNE 30, 2024

Aug 7 04:30 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 6 06:50 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTENTERS INTO OPTION AND LICENSE AGREEMENT WITH IDEAYAFOR POTENTIAL FIRST-IN-CLASS B7H3/PTK7 TOPO-I-PAYLOADBISPECIFIC ADC PROGRAM

Jul 31 05:30 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTENTERS INTO MULTI-TARGET ANTIBODY AGREEMENT WITH SOTIO

Jul 16 07:30 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 3 05:42 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENT Biocytogen Secures U.S. Patent for RenLiteCommon Light Chain Mouse Platform

Jun 21 04:30 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 6 05:29 ET

BIOCYTOGEN-B: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETINGHELD ON MAY 28, 2024

May 28 09:13 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 06:25 ET

BIOCYTOGEN-B: FORM OF PROXY FOR THE USE AT THE 2023 ANNUAL GENERAL MEETING

Apr 25 05:41 ET

BIOCYTOGEN-B: NOTICE OF THE 2023 ANNUAL GENERAL MEETING

Apr 25 05:40 ET

BIOCYTOGEN-B: (1)2023 ANNUAL REPORT... (2)WORK REPORT OF BOARD (3)WORK REPORT OF SUPERVISORY COMMITTEE (4)FINAL ACCOUNTS REPORT (5)PROPOSED RE-APPOINTMENT OF AUDITOR (6)PROPOSED REMUNERATION OF DIRECTORS (7)PROPOSED REMUNERATION OF SUPERVISORS (8)PROPOSED PROFIT DISTRIB

Apr 25 05:39 ET